PMID- 21049078
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220408
IS  - 1660-3796 (Print)
IS  - 1660-3818 (Electronic)
IS  - 1660-3796 (Linking)
VI  - 36
IP  - 4
DP  - 2009
TI  - HLA Genotyping and Antibody Characterization Using the Luminex Multiplex 
      Technology.
PG  - 273-278
AB  - The Luminex-based human leukocyte antigen (HLA) antibody screening technology is 
      widespread used in laboratories affiliated to kidney transplantation programs and 
      enables both screening (i.e. the definition of positive or negative antibody 
      status) and antibody identification with high sensitivity and specificity. HLA 
      typing at different levels of resolution with Luminex technology uses 
      sequence-specific oligonucleotide probes bound to color-coded microbeads in order 
      to identify HLA alleles encoded by the DNA sample. In general, the Luminex 
      technology for histocompatibility analyses provides rapid sample processing in a 
      96-well format combined with limited technical complexity which means high cost 
      efficiency.
FAU - Heinemann, Falko Markus
AU  - Heinemann FM
AD  - Institute for Transfusion Medicine, University Hospital Essen, Germany.
LA  - eng
PT  - Journal Article
DEP - 20090721
PL  - Switzerland
TA  - Transfus Med Hemother
JT  - Transfusion medicine and hemotherapy : offizielles Organ der Deutschen 
      Gesellschaft fur Transfusionsmedizin und Immunhamatologie
JID - 101176417
PMC - PMC2941832
EDAT- 2009/01/01 00:00
MHDA- 2009/01/01 00:01
PMCR- 2009/07/21
CRDT- 2010/11/05 06:00
PHST- 2009/04/14 00:00 [received]
PHST- 2009/07/09 00:00 [accepted]
PHST- 2010/11/05 06:00 [entrez]
PHST- 2009/01/01 00:00 [pubmed]
PHST- 2009/01/01 00:01 [medline]
PHST- 2009/07/21 00:00 [pmc-release]
AID - 228834 [pii]
AID - tmh0036-0273 [pii]
AID - 10.1159/000228834 [doi]
PST - ppublish
SO  - Transfus Med Hemother. 2009;36(4):273-278. doi: 10.1159/000228834. Epub 2009 Jul 
      21.